AMY B. HEIMBERGER, M.D.
Radiology at Holcombe Blvd, Houston, TX

License number

Texas L6422

Personal information

See more information about AMY B. HEIMBERGER at radaris.com

Name

Address

Phone

Amy Heimberger, age 57

412 E 7Th St, Houston, TX 77007

Amy B Heimberger

412 7Th St, Houston, TX 77007

(713) 880-4697

Amy B Heimberger, age 57

412 7Th St, Houston, TX 77007

(713) 880-4697

Amy A Heimberger, age 54

2500 Guerrero Dr, Carrollton, TX 75006

Organization information

See more information about AMY B. HEIMBERGER at bizstanding.com

University TX MD Anderson Cancer Center - Amy B Heimberger MD

1515 Holcombe Blvd UNIT 207, Houston, TX 77030

Categories:

Physicians & Surgeons

Phone:

(713) 792-6161 (Phone)

Professional information

See more information about AMY B. HEIMBERGER at trustoria.com

Dr. Amy B Heimberger, Houston TX - MD (Doctor of Medicine)

Specialties:

Neurosurgery

Address:

MD Anderson Cancer Center NSG
1515 Holcombe Blvd SUITE 339, Houston 77030
(713) 792-6600 (Phone)

Conditions:

Brain Cancer

Certifications:

Neurosurgery, 2005

Awards:

Healthgrades Honor Roll, American Association of Neurological Surgeons Young Clinical Investigator Award, 2003, American Association of Neurological Surgeons Preuss Award, 2000

Languages:

English, Spanish

Hospitals:

MD Anderson Cancer Center NSG
1515 Holcombe Blvd SUITE 339, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701

Education:

Medical School
Washington University St Louis
Graduated: 1995
Duke University Med Center
Graduated: 1996
Graduated: 2002
Graduated: 1999
University Of Missouri
Graduated: 1985

Amy B Heimberger, Houston TX

Specialties:

Neurosurgeon

Address:

1515 Holcombe Blvd, Houston, TX 77030

Education:

Washington University, School of Medicine - Doctor of Medicine
Duke University Hospital - Fellowship - Neuro-Oncology
Duke University Hospital - Residency - Neurological Surgery
Duke University Hospital - Internship - Surgery

Board certifications:

American Board of Neurological Surgery Certification in Neurological Surgery

Amy Beth Heimberger, Houston TX

Specialties:

Neurological Surgery, Surgical Oncology

Work:

University of Texas M.D. Anderson Cancer
1515 Holcombe Blvd, Houston, TX 77030

Education:

Washington University at St. Louis (1995) *, Duke University Medical Center (2002) *Neurological Surgery, Duke University Medical Center (2005) *Neurological Surgery

Blood Test For The Detection Of Cancer

US Patent:

2012002, Jan 26, 2012

Filed:

Jan 12, 2010

Appl. No.:

13/144250

Inventors:

Amy B. Heimberger - Houston TX, US

International Classification:

C40B 30/04

US Classification:

506 9

Abstract:

Methods of detecting cancers are provided. In certain embodiments, a blood test may utilized to identify the presence of a cancer such as, e.g., a melanoma or glioma (e.g., an astrocytoma, a glioblastoma multiforme) in a human patient. In particular, increased p-STAT3 expression by peripheral blood mononuclear cells is selectively associated with the presence of certain cancers. In various embodiments, fluorescence activated cell sorting (FACS) may be used to measure p-STAT3 expression in the peripheral blood of a human patient.

Interferon Therapies In Combination With Blockade Of Stat3 Activation

US Patent:

2013012, May 23, 2013

Filed:

Dec 4, 2010

Appl. No.:

13/513549

Inventors:

Waldemar Priebe - Houston TX, US
Amy Heimberger - Houston TX, US
Izabela Fokt - Houston TX, US
Timothy Madden - Sugarland TX, US
Charles Conrad - Spring TX, US

Assignee:

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX

International Classification:

A61K 38/21, A61K 31/165, A61K 31/706, A61K 31/4164, A61K 45/06, A61K 31/216, A61K 31/44, A61K 31/277

US Classification:

424 854

Abstract:

Methods of modulating the INF-induced STAT3 activation in a patient in need-thereof are provided for the treatment of disease. The methods comprise the step of administrating to a patient the combination of a therapeutically effective amount of interferon including INF-α and/or INF-β in combination with a STAT3 inhibitor.

Concurrent Chemotherapy And Immunotherapy

US Patent:

2009022, Sep 3, 2009

Filed:

Nov 2, 2006

Appl. No.:

12/092180

Inventors:

John H. Sampson - Durham NC, US
Darell D. Bigner - Mebane NC, US
Mitchell Duane - Durham NC, US
Amy Heimberger - Houston TX, US

Assignee:

Duke University - Durham NC
Univeristy of Texas M.D. Anderson Cancer Center - Houston TX

International Classification:

A61K 39/00, A61K 38/10, A61K 38/17, A61P 35/00

US Classification:

4242771, 514 14, 514 6, 4241841

Abstract:

The concurrent administration of chemotherapy and immunotherapy has been considered a contraindication because of the concern that the induced lymphopenia would ablate therapeutic efficacy of immunotherapy. Temozolomide has been shown to be an effective chemotherapeutic for patients with malignant gliomas and to deprive patients with glioblastoma (GBM) patients of this agent in order to treat with immunotherapy is controversial. Despite conventional dogma, we demonstrate that both chemotherapy and immunotherapy can be delivered concurrently without negating the effects of immunotherapy, in fact, the temozolomide induced lymphopenia may actually be synergistic with a peptide vaccine.

Small Molecule Inhibitors For Immune Modulation

US Patent:

2010014, Jun 10, 2010

Filed:

Mar 28, 2008

Appl. No.:

12/593280

Inventors:

Amy B. Heimberger - Houston TX, US
Waldemar Priebe - Houston TX, US
Izabela Fokt - Houston TX, US
Slawomir Szymanski - Houston TX, US
Sakina Hussain - Houston TX, US
Ling Y. Kong - Houston TX, US

International Classification:

A61K 31/44, A61P 37/04

US Classification:

514357

Abstract:

Methods of treating immunosuppression by administering a therapeutic amount of a tryphostin compound of the formula: